BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29204136)

  • 1. Suppression of Poxvirus Replication by Resveratrol.
    Cao S; Realegeno S; Pant A; Satheshkumar PS; Yang Z
    Front Microbiol; 2017; 8():2196. PubMed ID: 29204136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisbenzimide compounds inhibit the replication of prototype and pandemic potential poxviruses.
    Samolej J; Mendonca DC; Upfold N; McElwee M; Landsberger M; Yakimovich A; Patel AH; Strang BL; Mercer J
    Microbiol Spectr; 2024 Apr; 12(4):e0407223. PubMed ID: 38376353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1.
    Zhu J; Gao X; Li Y; Zhang Z; Xie S; Ren S; Li Y; Li H; Niu K; Fu S; Deng Y; Li Y; Moss B; Wu W; Peng C
    Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2304242120. PubMed ID: 37607234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulent Poxviruses Inhibit DNA Sensing by Preventing STING Activation.
    Georgana I; Sumner RP; Towers GJ; Maluquer de Motes C
    J Virol; 2018 May; 92(10):. PubMed ID: 29491158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Vaccinia Virus Inhibitors and Cellular Functions Necessary for Efficient Viral Replication by Screening Bioactives and FDA-Approved Drugs.
    Peng C; Zhou Y; Cao S; Pant A; Campos Guerrero ML; McDonald P; Roy A; Yang Z
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32708182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts.
    Dsouza L; Pant A; Offei S; Priyamvada L; Pope B; Satheshkumar PS; Wang Z; Yang Z
    Antiviral Res; 2023 Aug; 216():105651. PubMed ID: 37270160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
    Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
    J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination.
    Byrd D; Shepherd N; Lan J; Hu N; Amet T; Yang K; Desai M; Yu Q
    J Virol; 2014 Jun; 88(12):6819-31. PubMed ID: 24696488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus requires glutamine but not glucose for efficient replication.
    Fontaine KA; Camarda R; Lagunoff M
    J Virol; 2014 Apr; 88(8):4366-74. PubMed ID: 24501408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Poxvirus Gene Expression and Genome Replication by Bisbenzimide Derivatives.
    Yakimovich A; Huttunen M; Zehnder B; Coulter LJ; Gould V; Schneider C; Kopf M; McInnes CJ; Greber UF; Mercer J
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asparagine Is a Critical Limiting Metabolite for Vaccinia Virus Protein Synthesis during Glutamine Deprivation.
    Pant A; Cao S; Yang Z
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant Roles.
    Liu B; Panda D; Mendez-Rios JD; Ganesan S; Wyatt LS; Moss B
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
    Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
    J Virol; 2019 May; 93(10):. PubMed ID: 30814284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YTHDF2 Is Downregulated in Response to Host Shutoff Induced by DNA Virus Infection and Regulates Interferon-Stimulated Gene Expression.
    Hesser CR; Walsh D
    J Virol; 2023 Mar; 97(3):e0175822. PubMed ID: 36916936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Immunomodulatory Agents as a Complementary Therapy for Poxviruses.
    Ali SI; Salama A
    Adv Exp Med Biol; 2024; 1451():337-354. PubMed ID: 38801589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.
    Stuart CA; Zhivkoplias EK; Senkevich TG; Wyatt LS; Moss B
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Martínez-Sobrido L
    Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poxvirus Vaccines: Past, Present, and Future.
    Jhancy M
    Adv Exp Med Biol; 2024; 1451():273-287. PubMed ID: 38801584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication.
    Hagen CJ; Titong A; Sarnoski EA; Verardi PH
    Virus Res; 2014 Mar; 181():43-52. PubMed ID: 24394294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activities of two nucleos(t)ide analogs against vaccinia and mpox viruses in primary human fibroblasts.
    Dsouza L; Pant A; Offei S; Priyamvada L; Pope B; Satheshkumar PS; Wang Z; Yang Z
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.